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ABSTRACT: 1,1-Diacyloxy-1-phenylmethanes and 1-pivaloxy-1-acyloxy-1-phenylmethanes have been 
used as bench stable N-acylating reagents for primary and secondary amines and anilines under solvent-
free conditions to afford their corresponding amides in good yield.
N-Acylation reactions of primary and secondary 
amines are important transformations in organic 
chemistry, because they provide direct access to 
the highly versatile amide group.1 The amide bond 
occurs widely throughout nature and is present in 
many drug molecules, which means that N-acyla-
tion reactions are some of the most widely carried 
out transformations.2 Consequently a range of 
synthetic protocols have been developed that em-
ploy different reagents for N-acylation, many of 
which are used in the presence of catalysts to in-
crease their rate of reaction.2,3 For example, acyl 
chlorides are commonly employed as acylating 
agents for amines, often in conjunction with acyl 
transfer catalysts (e.g. DMAP), or Lewis acid cat-
alysts.2 However, there are problems associated 
with using acid chlorides, because they are vola-
tile, moisture-sensitive and easily hydrolyzed, 
whilst their reactions with amines are often exo-
thermic and produce HCl as a by-product that can 
cause problems in the presence of acid sensitive 
functional groups.4 Therefore, a range of alterna-
tive N-acylating reagents and conditions have 
been developed to address these problems,5 most 
notably the use of stoichiometric coupling agents 
(e.g. DCC) for peptide synthesis.6 A range of N-
acylating reagents for direct reaction with amines 
have also been developed for amide bond for-
mation, including N-acyl benzotriazoles,4 N-acyl 
DBN.BPh4 salts,
7 and 2-acyl-pyridazin-3-ones.8 
Given this precedent, we now report herein that 
1,1-acylals may be used as moisture tolerant N-ac-
ylating agents for amines and also demonstrate 
how mixed 1-pivaloxy-1-acyloxy-1-phenylme-
thanes 10a-h can be used as selective N-acyl trans-
fer agents.  
We have recently reported that formyloxyacetox-
yphenylmethane 1 can be used as a versatile N-
formylating reagent for amines under solvent free 
conditions, with exclusive transfer of its O-formyl 
group occurring over its O-acetyl group (Scheme 
1a).9 We reasoned that 1,1-acylals10 containing 
identical O-acyl groups might also function as 
useful reagents for the N-acylation of amines. A 
review of the literature revealed a single report 
where ethylidenene diacetate 2 had been used to 
N-acylate aniline under non-optimal conditions, to 
afford N-acetyl-acetanilide in 57% yield (Scheme 
1b).11 In this non-optimal protocol, aniline was re-
acted with ethylidene acetate in ether at rt for 1 h, 
with acetaldehyde and solvent then being removed 
by passing air through the reaction mixture for 1 h 
to afford a mixture that was fractionally distilled 
to afford acetic acid and acetanilide.11 
Given this precedent, we decided to carry out a full 
investigation into the potential of using benzyli-
dene diacetate (BDA) 3 as an acylating agent for 
amines.12 BDA 3 was chosen as an N-acylating 
agent to avoid potential side reactions that can 
arise from competing elimination reactions of ac-
etate groups from 1,1-diacylals such as ethylidene 
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diacetate 2 that would afford unwanted vinyl ace-
tates. 
Scheme 1: (a) Formyloxyacetoxyphenylmethane 
1 as an N-formylating agent for amines. (b) Ethyl-
idene diacetate 2 as an N-acetylating reagent for 
aniline.11 (c) Synthesis of benzylidene diacetate 
(BDA) 3 
  
BDA 3 was prepared in 95% yield via treatment 
of benzaldehyde and acetic anhydride with a cata-
lytic amount of para-toluene sulfonic acid (p-
TSA) (Scheme 1c).13 Initial treatment of 1 equiv. 
of benzylamine with 1.5 equiv. of BDA 3 in 
EtOAc, at rt for 2h resulted in formation of a 50:50 
mixture of the desired N-benzyl acetamide 4a and 
N-benzylidenebenzylamine 5 (Table 1, Entry 1). 
A solvent screen was then carried out to identify 
conditions that would suppress competing for-
mation of imine 5. Repeating the acetylation reac-
tion in toluene or CH2Cl2, gave similar results, af-
fording essentially 50:50 mixtures of acetamide 
4a and imine 5 (Table 1, Entries 2-3). Reaction of 
benzylamine with 1.5 or 5 equiv. of BDA 3 under 
solvent free conditions for 2 or 16 h also gave 
equimolar mixtures of acetamide 4a and imine 5 
(Table 1, Entries 4-6). However, using 1.5 equiv. 
of BDA 3 under solvent free conditions at 50 oC 
gave a 65:35 ratio of acetamide 4a:imine 5 after 
16 h (Table 1, Entry 7). Finally, carrying out the 
acetylation reaction of benzylamine at 70 °C for 
16 h gave a 95:5 ratio in favor of the desired acet-
amide 4a (Table 1, Entry 8). A solvent screen re-
vealed that EtOAc, toluene and CHCl3 could also 
be used as cosolvents where necessary, affording 
>90:10 ratio of acetamide 4a to imine 5 in each 
case.  
 
 
Table 1. Optimization of the N-acetylation reac-
tions of benzylamine using BDA 3 as an acyl do-
nor. 
 
Entry Solvent 
Time 
(h) 
Temp 
(°C) 
     4a:5  
1 EtOAc 2  rt 50:50 
2 toluene 2  rt 48:52 
3 CH2Cl2 2  rt 51:49 
4 - 2  rt 53:47 
5 - 16 rt 51:49 
6a - 16 rt 52:48 
7 - 16 50 65:35 
8 - 16 70 95:5 
9 EtOAc 16  70 90:10 
10 toluene 16   70 94:6 
11 CHCl3 16 70 92:8 
Product ratios determined from integrals of diag-
nostic resonances for 4a and 5 in 1H NMR spectra 
of crude reaction products. a5 equiv. of BDA 3 
used. 
Sampling the solvent free acetylation reactions of 
benzylamine using 1.5 equiv. of BDA 3 at 70 °C 
over time, revealed that the pH of the reaction 
mixture remained neutral around pH 7.0 until the 
majority of benzylamine had been consumed. Af-
ter this time, the reaction mixture became more 
acidic (pH 3.0). This study also revealed that all 
the benzylamine was consumed after 1 h affording 
a 60:40 ratio of acetamide 4a to imine 5 which 
gradually increased to a ratio of 95:5 in favor of 
amide 4a over the next 15 h. A plausible mecha-
nism (Figure 1) to explain these observations, in-
volves irreversible reaction of benzylamine with 
one of the acetyl groups of BDA 3 to afford acet-
amide 4a, with benzaldehyde and acetic acid being 
formed as by-products. The benzaldehyde pro-
duced may then react with benzylamine in a re-
versible manner to competitively afford imine 5. 
The acetic acid by-product may also react with 
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benzylamine to afford benzylammonium acetate 
6, which can act as a buffer to maintain neutrality 
in the initial stages of the acetylation reaction. 
Since formation of benzylammonium acetate 6 is 
reversible, equilibration may occur to regenerate 
benzylamine and acetic acid, which results in all 
the benzylamine eventually being consumed to af-
ford a 60:40 mixture of acetamide 4a and imine 5 
after 1 h. This equilibration process results in a 
gradual decrease in the amount of benzylammo-
nium acetate 6 present over time, that coincides 
with a proportional increase in the amount of ace-
tic acid present. Overall, this results in a decrease 
in buffering capacity (decrease in benzylammo-
nium acetate 6) and a decrease in pH (increase in 
acetic acid) of the reaction mixture as it proceeds 
beyond 1 h. The reversible nature of the acid-cat-
alysed imine bond forming reaction, results in 
gradual regeneration of benzylamine, that can then 
react irreversibly with BDA 3 to drive the equilib-
ria towards acetamide 4a formation. This results 
in gradual conversion of imine 5 into acetamide 4a 
over time, as witnessed by the change in ratio of 
acetamide 4a to imine 5 from 60:40 (1 h) to 95:5 
(16 h). 
Figure 1. Plausible mechanism for N-acetylation 
of benzylamine using BDA 3 as an acetyl donor. 
 With optimized conditions in hand, a range of pri-
mary and secondary amines were reacted with 1.5 
equiv. of BDA 3 under solvent free conditions at 
70 oC for 16 h which afforded fourteen acetamides 
4a-n in 60-95% isolated yields (Scheme 2). Most 
of these N- formylation reactions were carried out 
under solvent-free conditions, however, toluene 
was employed as a solvent where the parent amine 
was insoluble in neat BDA 3. Crude amide prod-
ucts could be purified directly via chromatog-
raphy, without the need for any aqueous work up. 
The primary amines benzylamine and 4-aminome-
thyl-pyridine were N-acetylated to afford acetam-
ides 4a-b in 84% and 86% yields respectively, 
whilst tryptamine was N-acetylated to afford acet-
amide 4c in 62% yield, with no acetylation of its 
indole nitrogen occurring. Sterically hindered 
benzhydrylamine gave its corresponding acetam-
ide 4d in 70% yield, whilst acyclic and cyclic sec-
ondary amines were acetylated to give 88-95% 
yields of the acetamides 4e-h, respectively. Pleas-
ingly, electron-deficient aniline and its secondary 
N-methyl analogue gave their corresponding acet-
amides 4i-j in 60-68% yields, with acetylation of 
electron deficient methyl para-aminobenzoate af-
fording acetamide 4k in 65% yield after 24 h. The 
selectivity of BDA 3 for N-acetylation over O-
acetylation was confirmed via treatment of L-ser-
ine methyl ester with 1.5 equiv. of BDA 3 at 70 °C 
for 16 h to afford N-acetyl-L-serine methyl ester 4l 
in 83% yield, with no evidence of any competing 
O-acetylation, or racemization having occurred. 
For example, N-acetylation of (S)--methylben-
zylamine gave (S)-N-(1-phenylethyl)acetamide 
4m in 89% yield which gave an [α]D25 of -143 (c 
1.0, EtOH), which compared favorably with the 
value previously reported for (S)-4m (>99% ee) of 
-145 (c 1.0, EtOH).14 Furthermore, N-acetylation 
of the methyl ester of dipeptide L-Leu-L-Leu pro-
ceeded in 65% yield, with only a single diastere-
omer (S,S)-4n being present in the 1H NMR spec-
tra of the crude reaction product. This means that 
this N-acylation reaction proceeds without epi-
merization and that reversible formation of the 
benzylimine of L-Leu-L-Leu proceeds in a racemi-
zation free manner. 
Our attention then turned to investigating the po-
tential of using other 1,1-acylals as reagents for 
the N-acylation of benzylamine with different acyl 
donors. Treatment of benzaldehyde with a range 
of acid anhydrides in the presence of a catalytic 
amount of PTSA for 12 h gave their corresponding 
1,1-acylals 7a-f in excellent 90-97% yield after 
chromatographic purification (Scheme 3). Synthe-
sis of highly reactive trifluoroacetyl 1,1-diacylal 
7f required use of 10 mol% of trifluoroacetic acid 
as catalyst for 12 h, which was used immediately 
without purification, due to its sensitivity to hy-
drolysis that led to rapid decomposition on stand-
ing. 
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Scheme 2: BDA 3 as an N-acetylating agent for 
primary and secondary amines. 
Reaction conditions: 1 mmol of amine, 1.5 equiv. 
BDA 3, 16 h, 70 °C. aToluene employed as sol-
vent. b24 h reaction time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Synthesis of a range of 1,1-acylals 7a-
f 
  
Reaction conditions; a1 equiv. benzaldehyde, 1.5 
equiv. acid anhydride, 10mol%, 70 °C, 16 h. 
pTSA. b1 equiv. benzaldehyde, 1.5 equiv. acid an-
hydride, 10mol% TFA, rt, 1 h.  
These 1,1-diacylal reagents 7a-e were then used to 
N-acylate benzylamine at 70 oC for 16 h with a 
range of acyl, benzoyl, and acryloyl groups being 
transferred under solvent free conditions to give 
five N-acyl benzylamides 8a-e in 79-96% yield re-
spectively (Scheme 4). The 1,1-trifluoroacylal re-
agent 7f proved to be much more reactive, with 
trifluoroacetylation of benzylamine proceeding to 
completion at rt after only 1 h to afford N-tri-
fluoroacetyl-benzylamide 8f in 91% yield 
(Scheme 4). 
We next decided to investigate whether mixed 1-
pivaloxy-1-acyloxy-1-phenylmethanes 10 could 
be used as selective N-acyl donors for amines. It 
was reasoned that the steric demand of the pivalic 
acid group of a mixed 1-pivaloxy-1-acyloxy-1-
phenylmethane 10 would prevent nucleophilic at-
tack at its proximal carbonyl, thus ensuring that 
selective transfer of its donor acyl group would oc-
cur. This would avoid the wastage of one equiva-
lent of the acylating group that occurs when sym-
metric 1,1-acylals 3, 7 are used as N-acylating re-
agents. In order to prepare these reagents, benzal-
dehyde was first treated with 1.5 equiv. of pivaloyl 
chloride, in the presence of a catalytic amount of 
p-TSA to afford chloro(phenyl)methyl pivalate 
9,15 that was then reacted immediately with a se-
ries of carboxylic acids and Et3N in acetone at 40 
°C to afford eight mixed 1-pivaloxy-1-acyloxy-1-
phenylmethanes 10a-h in 70-89% yield (Scheme 
5).16  
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Scheme 4. N-acylation reactions of benzylamine 
with 1,1-acylals 7a-f to afford N-acyl benzyla-
mides 8a-f 
 
Reaction conditions: a1 mmol of amine, 1.5 equiv. 
1,1-acylal 7a-e, 16 h, 70 °C. b1 mmol of amine, 1.5 
equiv. acylal 7f, rt, 1 h. 
Scheme 5. Synthesis of mixed 1-pivaloxy-1-
acyloxy-1-phenylmethanes 10a-h 
  
These mixed 1-pivaloxy-1-acyloxy-1-phenylme-
thanes 10a-h were then used to N-acylate a range 
of primary amines to give ten amides 4a, 8a, 8c, 
8e, 8g-l in 60-86% yield (Scheme 6). Pleasingly, 
no evidence of any products arising from pivaloyl 
transfer were detected in the 1H NMR spectra of 
the crude products of any of these reactions. 
Mixed pivaloyl acylals could be used for the N-
acylation of (S)-α-methylbenzylamine and (S)-
phenylalanine methyl ester to afford amides 8j-l 
with retention of configuration. The -amino 
group of α-N-Fmoc-L-lysine could also be acyl-
ated using 10b to afford amide (S)-8l in 70% yield, 
thus highlighting the potential of this type of 1,1-
acylal for carrying out N-acylation reactions on 
sensitive substrates under racemization free con-
ditions.  
Scheme 6. N-acylation reactions of 1-pivaloxy-1-
acyloxy-1-phenylmethanes 10a-h to afford N-acyl 
amides 4a, 8a, 8c, 8e, 8g-l 
 
In conclusion, we have shown that bench stable 
1,1-diacylals can be used as moisture-tolerant N-
acylating reagents for primary and secondary 
amines and anilines under solvent-free conditions, 
affording their corresponding acetamides in good 
yields. This N-acylation methodology has been 
further extended to enable mixed pivaloyl 1,1-ac-
ylals to be used as more efficient N-acylating 
agents for the selective transfer of donor acyl 
groups to a wide range of amines.  
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EXPERIMENTAL SECTION 
General conditions 
Unless preparative details are given, reagents and 
solvents were obtained from commercial suppli-
ers. All reactions were performed without air ex-
clusion, at room temperature and with magnetic 
stirring unless otherwise stated. Anhydrous 
MgSO4 or Na2SO4 were used as drying agents for 
organic solutions. Petrol refers to petroleum ether 
with a boiling range of 40-60 °C. Thin layer chro-
matography (TLC) was carried out on Macherey-
Nagel aluminium-backed plates that were pre-
coated with silica. Compounds were visualised by 
quenching of UV fluorescence at 254 nm or by 
staining with potassium permanganate, phospho-
molybdic acid (PMA) or vanillin dip followed by 
gentle heating. Purification by flash column chro-
matography was performed using high-purity 
grade 60 Å silica gel (60 Å pore size, 40-75 μm 
particle size). Capillary melting points were deter-
mined using a Stuart digital SMP10 melting point 
apparatus and are reported to the nearest °C. An 
Optical Activity Ltd AA-10 Series Automatic Po-
larimeter with a path length of 1 dm was used to 
measure optical rotations, with concentration (c) 
quoted in g/100 mL.  Nuclear Magnetic Reso-
nance (NMR) spectroscopy experiments were per-
formed in deuterated solvent at 298 K on either a 
Brüker Avance 250, 300, 400 or 500 MHz spec-
trometer or an Agilent ProPulse 500 MHz spec-
trometer, with proton decoupling used for all 13C 
NMR spectra. 1H and 13C NMR chemical shifts, δ, 
are quoted in parts per million (ppm) and where 
possible are referenced against the residual, non-
deuterated solvent peak. A PerkinElmer Spectrum 
100 FTIR spectrometer with Universal ATR FTIR 
accessory was used to record infrared (IR) spectra; 
with samples run neat and the most relevant, char-
acteristic absorbances quoted as ν in cm-1. High 
resolution mass spectrometry (HRMS) results 
were acquired on an externally calibrated Bruker 
Daltonics micrOTOFTM time-of-flight mass spec-
trometer coupled to an electrospray source (ESI-
TOF). Molecular ions were detected in positive 
mode as either the protonated or sodiated form, 
with Bruker Daltonics software, DataAnalysisTM 
used to process the data.  
General Procedures General Procedure A: N-
acetylation of amines 
Amine (1.0 mmol) was added to phenylmethylene 
diacetate 3 (0.291 g, 1.5 mmol) and the reaction 
stirred at 70 °C for 16 h. The crude reaction prod-
uct was then purified by silica gel chromatography 
to give the desired acetamide. In those cases, 
where the reaction mixture was not homogeneous, 
then 2 mL of EtOAc or toluene were added as 
cosolvent at the start of the reaction. These reac-
tions were worked-up by removing the cosolvent 
in vacuo, followed by purification of the crude re-
action product by chromatography. 
General Procedure B: Synthesis of acylals 
para-Toluenesulfonic acid (mono hydrate) (0.18 
g, 0.94 mmol) was added to a mixture of benzal-
dehyde (1.0 g, 9.4 mmol) and anhydride (18.8 
mmol) at rt. The reaction was stirred for 12 h and 
then diluted with Et2O (50 mL) and washed with 
saturated Na2CO3 (3 x 20 mL). The organics were 
dried (MgSO4) and concentrated in vacuo to give 
the title compound which was used without further 
purification unless stated otherwise.  
General Procedure C: N-acylation of amines  
Amine (1.0 mmol) was added to the acylating re-
agent (1.5 mmol) and the reaction stirred at 70 °C 
for 16 h. The crude reaction product was then pu-
rified by silica gel chromatography to give the de-
sired amide.  
General Procedure D: Synthesis of mixed acyl-
als  
Trimethylacetyl chloride (0.813 mL, 6.60 mmol) 
was added dropwise to a mixture of benzaldehyde 
(0.489 g, 4.40 mmol) and para-toluenesulfonic 
acid (0.083 g, 0.44 mmol) at rt and the reaction 
mixture stirred for 3 h. The reaction was then 
quenched via addition of saturated NaHCO3(aq)  
(10 mL) and diluted with Et2O (50 mL). The reac-
tion was then extracted with saturated NaHCO3(aq) 
(3 x 20 mL), the organic layer dried (MgSO4) and 
concentrated in vacuo to afford chloro(phenyl)me-
thyl pivalate (1.0 g, 4.40 mmol) as a yellow oil that 
was used without further purification. Triethyla-
mine (0.60 mL, 4.40 mmol) was added dropwise 
to a solution of chloro(phenyl)methyl pivalate 
(4.40 mmol) and carboxylic acid (4.40 mmol) in 
  
9 
acetone (10 mL). The reaction was stirred at 40 °C 
for 12 h during which time a white ppt formed. 
The reaction product was then filtered through 
celite® and concentrated in vacuo to afford a crude 
reaction product that was purified by silica gel 
chromatography (5% EtOAc in pet ether) to give 
the title compound.  
Phenylmethylene diacetate 315 
General procedure B was followed to afford the 
title compound as a clear oil in 98% yield (1.92 g, 
9.21 mmol). 1H NMR (300 MHz, CDCl3) δ 7.68 
(s, 1H, CH(OAc)2), 7.55 – 7.48 (m, 2H, ArH), 7.46 
– 7.37 (m, 3H. ArH), 2.13 (s, 6H, 2 x CH3). 13C 
NMR (75 MHz, CDCl3) δ 169.0, 135.6, 129.9, 
128.8, 126.8, 89.8, 21.0. I.R (thinfilm) νmax (cm-1): 
2981 (ArC-H), 1746 (C=O); HRMS (ESI): m/z 
calculated for C11H12O4: requires: 231.0633 for 
[M+Na]+; found: 231.0683. 
N-Benzylacetamide 4a17 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)] to afford the title 
compound as a cream solid in 86% yield (0.128 g, 
0.86 mmol). m.p. 61-62 °C (lit.18 61-62 °C).  1H 
NMR (300 MHz, CDCl3); δ 7.39 – 7.21 (m, 5H, 
ArH), 5.89 (s, 1H, NH), 4.42 (d, J = 5.7 Hz, 2H, 
CH2), 2.01 (s, 3H, CH3). 
13C NMR (75 MHz, 
CDCl3) δ 170.0, 138.3, 128.8, 128.0, 127.7, 43.9, 
23.4. 
N-(Pyridin-4-ylmethyl)acetamide 4b19 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc:Et3N (70:29:1)] to afford 
the title compound as an orange oil in 84% yield 
(0.126 g, 0.84 mmol). 1H NMR (300 MHz, 
CDCl3) δ 8.58 – 8.48 (m, 2H, ArH), 7.22 – 7.14 
(m, 2H, ArH), 6.07 (s, 1H, NH), 4.44 (d, J = 6.1 
Hz, 2H, CH2), 2.07 (s, 3H, CH3). 
13C NMR (75 
MHz, CDCl3) δ 170.4, 150.1, 147.5, 122.4, 42.6, 
23.3. 
N-(2-(1H-Indol-3-yl)ethyl)acetamide 4c20 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [EtOAc] to give the title compound as a pale 
brown solid in 62% yield (0.125 g, 0.62 mmol). 
m.p. 76-78 °C (lit.21 77-78°C) 1H NMR (300 
MHz, CDCl3) δ 8.16 (s, 1H, NH), 7.61 (ddt, J = 
7.8, 1.5, 0.8 Hz, 1H, ArH), 7.39 (dt, J = 8.1, 1.0 
Hz, 1H, ArH), 7.22 (ddd, J = 8.2, 7.0, 1.3 Hz, 1H, 
ArH), 7.13 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H, ArH), 
7.06 – 7.03 (m, 1H, ArH), 5.54 (s, 1H, NH), 3.60 
(q, J = 6.5 Hz, 2H, CH2CH2NH), 2.98 (td, J = 6.7, 
0.9 Hz, 2H, CH2CH2NH), 1.92 (s, 3H, CH3). 
13C 
NMR (75 MHz, CDCl3) δ 170.2, 136.5, 127.5, 
122.4, 122.2, 119.7, 118.8, 113.1, 111.4, 77.4, 
39.9, 25.4, 23.6. 
N-Benzhydrylacetamide 4d22 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (80:20] to afford the title 
compound as a crystalline white solid in 70% yield 
(0.158 g, 0.70 mmol). m.p. 148-150 °C (lit.23 151 
°C) 1H NMR (300 MHz, CDCl3) δ 7.32 (qt, J = 
6.2, 1.8 Hz, 5H, ArH), 7.30 – 7.18 (m, 5H, ArH), 
6.26 (d, J = 8.0 Hz, 1H, CH), 6.04 (s, 1H, NH), 
2.08 (s, 3H, CH3).
 13C NMR (75 MHz, CDCl3) δ 
169.2, 141.6, 128.8, 127.6, 127.5, 57.1, 23.6. 
N,N-Dibutylacetamide 4e24  
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)]  to afford the title 
compound as a clear oil in 90% yield (0.154 g, 
0.90 mmol). 1H NMR (300 MHz, CDCl3) δ 3.33 – 
3.24 (m, 2H, NCH2), 3.23 – 3.15 (m, 2H, NCH2), 
2.06 (s, 3H, CH3), 1.49 (dddd, J = 15.2, 9.2, 7.8, 
5.4 Hz, 4H, CH2CH2CH2), 1.30 (hept, J = 7.4 Hz, 
4H, CH2CH2CH3), 0.92 (dt, J = 10.0, 7.3 Hz, 6H, 
2x CH2CH3). 
13C NMR (75 MHz, CDCl3) δ 170.2, 
48.7, 45.6, 31.1, 30.0, 21.7, 20.4, 20.2, 14.0, 14.0. 
N,N-Diallylacetamide 4f24 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)] to afford the title 
compound as a yellow oil in 88% yield (0.122 g, 
0.88 mmol). 1H NMR (300 MHz, CDCl3) δ 5.86 – 
5.64 (m, 2H, CH=CH2), 5.25 – 5.04 (m, 4H, 
CH=CH2), 3.98 (dt, J = 6.1, 1.4 Hz, 2H, NCHaHb), 
3.86 (dt, J = 4.9, 1.8 Hz, 2H, NCHaHb), 2.09 (s, 
3H, CH3).
13C NMR (75 MHz, CDCl3) δ 170.8, 
133.4, 132.7, 117.4, 116.7, 50.1, 47.9, 21.5. 
1-(Piperidin-1-yl)ethanone 4g17 
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General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (80:20)] to afford the title 
compound as a yellow oil in 95% yield (0.121 g, 
0.95 mmol). 1H NMR (300 MHz, CDCl3) δ 3.59 – 
3.49 (m, 2H, NCHAX), 3.38 (dd, J = 6.2, 4.6 Hz, 
2H, NCHEQ), 2.07 (s, 3H, CH3), 1.71 – 1.43 (m, 
6H, CH2CH2CH2). 
13C NMR (75 MHz, CDCl3) δ 
168.9, 47.6, 42.6, 26.6, 25.6, 24.6, 21.7. 
1-(4-Methylpiperazin-1-yl)ethanone 4h25 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)]  to afford the title 
compound as a yellow oil in 92% yield (0.131 g, 
0.92 mmol). 1H NMR (300 MHz, CDCl3) δ 3.69 – 
3.58 (m, 2H, AcNCHAX), 3.51 – 3.42 (m, 2H, Ac-
NCHEQ), 2.38 (dt, J = 10.0, 5.2 Hz, 4H, 
CH2NCH3), 2.30 (s, 3H, CH2NCH3), 2.08 (s, 3H, 
(C=O)CH3). 
13C NMR (75 MHz, CDCl3) δ 169.1, 
55.2, 54.7, 46.3, 46.1, 41.4, 21.5. 
N-Phenylacetamide 4i17 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (80:20)]  to afford the title 
compound as a pale yellow solid in 68% yield 
(0.92 g, 0.68 mmol). m.p. 114-115 °C (lit.26 114-
115 °C). 1H NMR (300 MHz, CDCl3) δ 7.54 – 7.45 
(m, 2H, ArH), 7.32 (t, J = 7.9 Hz, 2H, ArH), 7.15 
– 7.06 (m, 1H, ArH), 2.18 (s, 3H, CH3). 13C NMR 
(75 MHz, CDCl3) δ 168.4, 138.0, 129.2, 124.5, 
119.9, 24.8. 
N-Methyl-N-phenylacetamide 4j27 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)] to afford the title 
compound as a pale green solid in 60% yield 
(0.089 g, 0.60 mmol). m.p. 100-102 °C (lit.28 101-
102 °C).  1H NMR (300 MHz, CDCl3) δ 7.42 (dd, 
J = 8.3, 6.5 Hz, 2H, ArH), 7.37 – 7.30 (m, 1H, 
ArH), 7.23 – 7.15 (m, 2H, ArH), 3.27 (s, 3H, 
NCH3), 1.87 (s, 3H, CH3). 
13C NMR (75 MHz, 
CDCl3) δ 170.7, 144.7, 129.9, 127.8, 127.2, 37.3, 
22.6. 
Methyl 4-acetamidobenzoate 4k29 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)]  to afford the title 
compound as a pale yellow solid in 65% yield 
(0.126 g, 0.65 mmol). m.p. 126-128 °C (lit.30 128 
°C). 1H NMR (300 MHz, CDCl3) δ 8.08 – 7.92 (m, 
2H, ArH), 7.59 (d, J = 8.4 Hz, 2H, ArH), 7.42 (s, 
1H, NH), 3.90 (s, 3H, CO2CH3), 2.21 (s, 3H, CH3). 
13C NMR (75 MHz, CDCl3) δ 168.6, 166.7, 142.2, 
131.0, 125.7, 118.8, 52.2, 25.0. 
(S)-Methyl 2-acetamido-3-hydroxypropanoate 4l 
Et3N (0.42 mL, 3.21 mmol) was added in a drop-
wise manner to a stirred suspension of serine me-
thyl ester hydrochloride salt (0.5 g, 3.21 mmol) in 
acetone (3 mL). The reaction mixture was stirred 
for 10 min, filtered through a Celite® pad, and the 
filtrate concentrated in vacuo to give serine methyl 
ester which was used as a substrate for N-acylation 
without further purification.  
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:MeOH (95:5)]  Eluent 5% to afford 
the title compound as a brown oil in 83% yield 
(0.428 g, 2.56 mmol), [α]D20 = -9.5 MeOH; 1H 
NMR (500 MHz, CDCl3) δ 6.52 (s, 1H, NH), 4.67 
(dt, J = 7.3, 3.6 Hz, 1H, CHNH), 3.95 (qd, J = 
11.2, 3.6 Hz, 2H, CH2OH), 3.79 (s, 3H, OCH3), 
2.80 (s, 1H, OH), 2.07 (s, 3H, (C=O)CH3), 
13C 
NMR (126 MHz, CDCl3) δ 171.1, 170.8, 63.6, 
54.9, 52.9, 23.3. [α]D20 = -9.5 in MeOH. I.R (thin-
film) νmax (cm-1): 3291 ((C=O)NH and OH), 1738, 
1648 (C=O); HRMS (ESI): m/z calculated for 
C6H11NO4: requires: 162.0766 for [M+H]
+; found: 
162.0788. 
(S)-N-(1-phenylethyl)acetamide 4m 
General procedure A was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (60:40)] to afford the title 
compound as a white solid in 89% yield (0.145 g, 
0.89 mmol). [α]D20 = -143 (c 1.0, EtOH) (lit.14a 
[α]D20 = -145 (c 1.0, EtOH), >99% ee). m.p. 97-99 
°C (lit.14b 99-100 °C). 1H NMR (300 MHz, 
CDCl3); δ 7.39 – 7.26 (m, 5H, ArH), 5.67 (s, 1H, 
NH), 5.23 – 5.03 (m, 1H, CHN), 1.99 (s, 3H. CH3), 
1.49 (d, J = 6.9 Hz, 3H, PhCHCH3). 
13C NMR (75 
MHz, CDCl3) δ 169.2, 143.2, 128.8, 127.6, 126.4, 
48.94, 23.7, 21.8. 
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N-acetyl-L,L-leucyl-leucine methyl ester 4n 
General procedure C was followed to afford a 
crude product was purified by chromatography 
[petroleum ether:EtOAc (90:10)] to give the title 
compound as a white solid (0.189g, 0.63 mmol) in 
63% yield. m.p. 99 - 101 °C, [α]D20 = -52 (c 1.0, 
CHCl3).
 1H NMR (500 MHz, CDCl3) δ = 6.39 (d, 
1H, J = 8.0 Hz, 1H, NH), 5.96 (d, 1H, J = 8.0 Hz, 
NH), 4.59 – 4.55 (m, 1H, NCH), 4.50-4.55 (m, 1H, 
NCH), 3.73 (s, 3H, OCH3), 2.00 (s, 3H, 
C(=O)CH3), 1.63 – 1.49 (m, 6H, 2CH2 and 
2CH2CH(CH3)2), 0.95 – 0.91 (m, 12H, 
2CH(CH3)2) .
 13C NMR (126 MHz, CDCl3) δ = 
173.2, 172.0, 170.2, 52.5, 51.7, 50.9, 41.5, 41.3, 
25.0, 24.9, 23.3, 23.0, 22.9, 22.4, 22.0. I.R (thin-
film) νmax (cm-1): 3275, 3072, 2957, 1749 (C=O 
ester), 1643 (C=O amide), 1547 (C=O amide). 
HRMS (ESI): m/z calculated for C15H28N2O4: re-
quires: 323.1941 for [M+Na]+; found: 323.1941. 
Phenylmethylene dipropionate 7a31 
General procedure B was followed to afford the 
title compound as a clear oil in 97% yield (2.15 g, 
9.12 mmol).1H NMR (300 MHz, CDCl3) δ 7.71 (s, 
1H, CH(OCOEt)2), 7.51 (qd, J = 3.8, 1.5 Hz, 2H, 
ArH), 7.41 (ddt, J = 4.3, 3.1, 1.6 Hz, 3H, ArH), 
2.40 (tt, J = 7.4, 3.6 Hz, 4H, 2 x CH2CH3), 1.16 (t, 
J = 7.5 Hz, 6H, 2 x CH2CH3). 
13C NMR (75 MHz, 
Chloroform-d) δ 172.47, 135.81, 129.80, 128.72, 
126.78, 89.72, 27.55, 8.89. I.R (thinfilm) νmax (cm-
1): 2983 (ArC-H), 1756 (C=O); HRMS (ESI): m/z 
calculated for C13H12O4: requires: 259.0946 for 
[M+Na]+; found: 259.0995. 
Phenylmethylene dihexanoate 7b32 
General procedure B was followed to afford the 
title compound as a clear oil in 96% yield (2.89 g, 
9.02 mmol). 1H NMR (300 MHz, Chloroform-d) 
δ 7.71 (s, 1H, CHPh), 7.51 (qd, J = 3.7, 1.5 Hz, 
2H, ArH), 7.40 (ddt, J = 4.2, 3.1, 1.6 Hz, 3H, 
ArH), 2.37 (td, J = 7.4, 2.3 Hz, 4H, 2 x 
(C=O)CH2CH2), 1.70 – 1.58 (m, 4H, 2 x 
(C=O)CH2CH2), 1.30 (dq, J = 7.2, 3.7, 3.3 Hz, 8H, 
2 x (C=O)CH2CH2), 0.94 – 0.82 (m, 6H, 2 x 
CH2CH2CH3). 
13C NMR (75 MHz, Chloroform-d) 
δ 171.8, 135.9, 129.8, 128.7, 126.8, 89.6, 34.2, 
31.3, 24.5, 22.4, 14.0. I.R (thinfilm) νmax (cm-1): 
2956 (ArC-H), 1752 (C=O); HRMS (ESI): m/z 
calculated for C19H28O4: requires: 343.1885 for 
[M+Na]+; found: 343.1898. 
Phenylmethylene bis(2-phenylacetate) 7c 
General procedure B was followed to afford the 
title compound as a clear oil in a 94% yield (3.18 
g, 8.84 mmol). 1H NMR (250 MHz, CDCl3) δ 7.69 
(s, 1H, CHPh), 7.43 – 7.16 (m, 15H, ArH), 3.64 
(s, 4H, 2 x CH2Ph). 
13C NMR (75 MHz, CDCl3) δ 
169.5, 135.3, 133.2, 129.9, 129.5, 129.4, 128.7, 
127.4, 126.7, 90.3, 41.1. I.R (thinfilm) νmax (cm-1): 
3032, 2981 (ArC-H), 1759 (C=O); HRMS (ESI): 
m/z calculated for C23H20O4: requires: 383.1259 
for [M+Na]+; found: 383.1259. 
Phenylmethylene dibenzoate 7d31 
General procedure B was followed to afford the 
title compound as a clear oil in 99% yield (3.09 g, 
9.30 mmol). 1H NMR (300 MHz, CDCl3) δ 8.25 – 
8.06 (m, 5H, CH and ArH), 7.75 – 7.64 (m, 3H, 
ArH), 7.62 – 7.50 (m, 4H, ArH), 7.49 – 7.40 (m, 
4H, ArH). 13C NMR (75 MHz, CDCl3) δ 164.6, 
162.5, 134.7, 133.7, 130.7, 130.2, 129.9, 129.2, 
129.0, 128.9, 128.6, 126.9, 90.8. I.R (thinfilm) 
νmax (cm-1): 3064 (ArC-H), 1722 (C=O); HRMS 
(ESI): m/z calculated for C21H16O4: requires: 
355.0946 for [M+Na]+; found: 355.0929. 
Phenylmethylene diacrylate 7e 
General procedure B was followed to afford the 
title compound as a clear oil in 97% yield (2.12 g, 
9.12 mmol). 1H NMR (300 MHz, Chloroform-d) 
δ 7.87 (s, 1H, CHPh), 7.65 – 7.48 (m, 2H, ArH), 
7.51 – 7.36 (m, 3H, ArH), 6.52 (dd, J = 17.3, 1.4 
Hz, 2H, CHaHb=CH), 6.27 – 6.03 (m, 2H, 
CHaHb=CH), 5.93 (dd, J = 10.5, 1.3 Hz, 2H, 
CHaHb=CH). 
13C NMR (75 MHz, Chloroform-d) 
δ 164.0, 134.8, 132.8, 129.9, 128.8, 127.6, 126.8, 
90.1. I.R (thinfilm) νmax (cm-1): 3040 (ArC-H), 
1732 (C=O); HRMS (ESI): m/z calculated for 
C13H12O4: requires: 255.0633 for [M+Na]
+; 
found: 255.0667. 
Phenylmethylene bis(2,2,2-trifluoroacetate) 7f 
Trifluoroacetic acid (0.035 mL, 0.47 mmol) was 
added in a dropwise manner to a solution of ben-
zaldehyde (0.50 g, 4.7 mmol) and trifluoroacetic 
anhydride (0.98 mL, 7.08 mmol) at rt. After 2 h, 
the reaction was concentrated in vacuo to give the 
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title compound as a yellow oil in 95% yield (1.4 g, 
4.5 mmol). 1H NMR (300 MHz, CDCl3) δ 7.79 (s, 
1H, ArH), 7.62 – 7.45 (m, 5H, ArH). 13C NMR (75 
MHz, CDCl3) δ 155.3 (q, 2JC-F = 44.7 Hz), 134.4, 
131.8, 129.4, 127.0, 114.1 (q, 1JC-F = 285.5 Hz), 
93.8. I.R (thinfilm) νmax (cm-1): 1809 (C=O)    
N-Benzylpropionamide 8a33  
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)] to give the title 
compound as a fluffy white solid in 95% yield 
(0.155 g, 0.95 mmol). m.p. 49-50 °C (lit.34 49-50 
°C). 1H NMR (300 MHz, CDCl3) δ 7.39 – 7.22 (m, 
5H, ArH), 5.80 (s, 1H, NH), 4.43 (d, J = 5.7 Hz, 
2H, CH2Ph), 2.24 (q, J = 7.6 Hz, 2H, CH2CH3), 
1.18 (t, J = 7.6 Hz, 3H, CH2CH3). 
13C NMR (75 
MHz, CDCl3) δ 173.7, 138.5, 128.8, 128.0, 127.6, 
43.7, 29.8, 10.0. 
N-Benzylhexanamide 8b35 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)] to give the title 
compound as a white solid in 91% yield (0.186 g, 
0.91 mmol). m.p. 53-55 °C (lit.36 54-55 °C). 1H 
NMR (300 MHz, CDCl3) δ 7.39 – 7.26 (m, 5H, 
ArH), 5.68 (s, 1H, NH), 4.45 (d, J = 5.7 Hz, 2H, 
CH2Ph), 2.21 (dd, J = 8.6, 6.7 Hz, 2H, 
(C=O)CH2CH2CH2), 1.73 – 1.60 (m, 2H, 
(C=O)CH2CH2CH2), 1.32 (dq, J = 7.2, 3.8, 3.2 Hz, 
4H, (C=O)CH2CH2CH2CH2), 0.95 – 0.83 (m, 3H, 
CH3). 
13C NMR (75 MHz, CDCl3) δ 173.1, 138.5, 
128.9, 128.0, 127.7, 43.7, 37.0, 31.6, 25.6, 22.6, 
14.1. 
N-Benzyl-2-phenylacetamide 8c35 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)] to give the title 
compound as a pale brown solid in a 79% yield 
(0.178 g, 0.79 mmol). m.p. 120-122 °C (lit.37 121-
123 °C). 1H NMR (300 MHz, CDCl3) δ 7.26 (s, 
8H, ArH), 7.22 – 7.13 (m, 2H, ArH), 5.69 (s, 1H, 
NH), 4.42 (d, J = 5.8 Hz, 2H, PhCH2NH), 3.64 (s, 
2H, PhCH2). 
13C NMR (75 MHz, CDCl3) δ 171.0, 
138.2, 134.9, 129.6, 129.2, 128.8, 127.6, 127.6, 
44.0, 43.7. 
N-Benzylbenzamide 8d33 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)] to give the title 
compound as a cream solid in 87% yield (0.184 g, 
0.87 mmol). m.p. 105-106 °C (lit.38 105.8-106.2 
°C). 1H NMR (300 MHz, CDCl3) δ 7.84 – 7.68 (m, 
2H, ArH), 7.56 – 7.28 (m, 8H, ArH), 6.40 (s, 1H, 
NH), 4.66 (d, J = 5.6 Hz, 2H. CH2Ph). 
13C NMR 
(75 MHz, CDCl3) δ 167.5, 138.3, 134.5, 131.7, 
129.0, 128.8, 128.1, 127.8, 127.1, 44.3. 
N-Benzylacrylamide 8e39 
General procedure C was followed. to afford a 
crude product that was purified by chromatog-
raphy [CH2Cl2:EtOAc (70:30)] to give the title 
compound as a cream solid in 96% yield (0.154 g, 
0.96 mmol). m.p. 58-59 °C (lit.40 58-59 °C). 1H 
NMR (300 MHz, CDCl3) δ 7.40 – 7.27 (m, 5H, 
ArH), 6.33 (dd, J = 16.9, 1.5 Hz, 1H, CH=CHaHb), 
6.11 (dd, J = 17.0, 10.2 Hz, 1H, CH=CHaHb), 5.88 
(s, 1H, NH), 5.67 (dd, J = 10.2, 1.5 Hz, 1H, 
CH=CHaHb), 4.52 (d, J = 5.8 Hz, 2H, CH2Ph). 
13C 
NMR (75 MHz, CDCl3) δ 165.5, 138.1, 130.7, 
128.9, 128.7, 128.7, 128.1, 128.0, 127.8, 127.0, 
126.8, 43.8. 
N-Benzyl-2,2,2-trifluoroacetamide 8f41 
Benzylamine (0.107 g, 1.0 mmol) was added to 
phenylmethylene- bis(2,2,2-trifluoroacetate) 
(0.474 g, 1.5 mmol) and the reaction mixture 
stirred at rt for 1 h. The crude reaction product was 
then purified by chromatography [CH2Cl2:EtOAc 
(70:30)] to give the title compound as a white solid 
in 91% yield (0.184 g, 0.91 mmol). m.p. 74-76 °C 
(lit.42 75-76 °C). 1H NMR (300 MHz, CDCl3) δ 
7.43 – 7.33 (m, 3H, ArH), 7.32 – 7.27 (m, 2H, 
ArH), 6.63 (s, 1H, NH), 4.53 (d, J = 5.8 Hz, 2H, 
CH2). 
13C NMR (75 MHz, CDCl3) δ 157.3 (q, 2JC-
F = 37.2 Hz), 135.9, 129.1, 128.4, 128.1, 116.0 (q, 
1JC-F = 287.8 Hz), 44.0.  
Acetoxy(phenyl)methyl pivalate 10a 
General procedure D was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (95:5)] to give the 
title compound as a clear oil in 89% yield (0.97 g, 
3.92 mmol). 1H NMR (300 MHz, CDCl3)) δ 7.7 
(s, 1H, OCHO), 7.6 – 7.4 (m, 2H, ArH), 7.5 – 7.3 
(m, 3H, ArH), 2.1 (s, 3H, C(O)CH3), 1.2 (s, 9H, 
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C(O)C(CH3)3). 
13C NMR (75 MHz, CDCl3)) δ 
176.4, 169.1, 135.8, 129.7, 128.7, 126.7, 89.9, 
39.0, 27.0, 21.1. I.R (thin film) νmax (cm-1): 1745 
(C=O). HRMS (ESI): m/z calculated for 
C14H18O4: requires: 273.11027 for [M+Na]
+; 
found: 273.1103. 
Phenyl(2-phenylacetoxy)methyl pivalate 10b 
General procedure D was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (95:5)] to give the 
title compound as a clear oil in 84% yield (1.20 g, 
3.69 mmol). 1H NMR (300 MHz, Chloroform-d) 
δ 7.7 (s, 1H, OCHO), 7.5 – 7.4 (m, 2H, ArH), 7.5 
– 7.3 (m, 3H, ArH), 7.4 – 7.2 (m, 5H, ArH), 3.7 (s, 
2H, CH2Ph), 1.2 (s, 9H, C(CH3)3). 
13C NMR (75 
MHz, Chloroform-d) δ 176.3, 169.6, 135.7, 133.4, 
129.7, 129.4, 128.7, 128.7, 127.4, 126.6, 90.0, 
41.3, 38.9, 27.0. I.R (thinfilm) νmax (cm-1): 2995, 
2983 (ArC-H), 1769, 1756 (C=O); HRMS (ESI): 
m/z calculated for C20H22O4: requires: 349.1410 
for [M+Na]+; found: 349.1473. 
Phenyl(propionyloxy)methyl pivalate 10c 
General procedure D was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (95:5)] to give the 
title compound as a clear oil a 82% yield (0.95 g, 
3.62 mmol).1H NMR (300 MHz, Chloroform-d) δ 
7.7 (s, 1H, OCHO), 7.5 – 7.4 (m, 2H, ArH), 7.4 – 
7.4 (m, 3H, ArH), 2.4 (qd, J = 7.5, 3.0 Hz, 2H, 
CH2CH3), 1.2 (s, 9H, C(CH3)3), 1.2 (t, J = 7.5 Hz, 
3H, CH2CH3).
  13C NMR (75 MHz, Chloroform-d) 
δ 176.4, 172.5, 135.9, 129.7, 128.7, 126.7, 89.8, 
39.0, 27.6, 27.0, 9.0. I.R (thinfilm) νmax (cm-1): 
2978 (ArC-H), 1754, 1750 (C=O); HRMS (ESI): 
m/z calculated for C15H20O4: requires: 287.1254 
for [M+Na]+; found: 287.1268. 
Phenyl(pivaloyloxy)methyl acrylate 10d 
General procedure D was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (95:5)] to give the 
title compound as a clear oil in 82% yield (0.94 g, 
3.61 mmol). 1H NMR (300 MHz, Chloroform-d) 
δ 7.8 (s, 1H, OCHO), 7.6 – 7.5 (m, 2H, ArH), 7.5 
– 7.4 (m, 3H, ArH), 6.5 (dd, J = 17.3, 1.4 Hz, 1H, 
CH=CHaHb), 6.2 (dd, J = 17.3, 10.4 Hz, 1H, 
CH=CHaHb), 5.9 (dd, J = 10.4, 1.4 Hz, 1H, 
CH=CHaHb), 1.2 (s, 9H, C(CH3)3). 
13C NMR (75 
MHz, Chloroform-d) δ 176.4, 164.1, 135.8, 132.6, 
129.8, 128.7, 127.7, 126.7, 90.0, 39.0, 27.0. I.R 
(thinfilm) νmax (cm-1): 2975, 2875 (ArC-H), 1744 
(C=O); HRMS (ESI): m/z calculated for 
C15H18O4: requires: 285.1097 for [M+Na]
+; 
found: 285.1149.  
Phenyl(pivaloyloxy)methyl benzoate 10e 
General procedure D was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (95:5)] to give the 
title compound as a colourless oil (0.874 g, 2.80 
mmol) in 70% yield. 1H NMR (500 MHz, CDCl3) 
δ = 8.08 (d, J = 7.3 Hz, 2H, ArH), 7.94 (s, 1H, 
CHPh), 7.61 – 7.42 (m, 8H, ArH), 1.25 (s, 9H, 
3xCH3).
 13C NMR (125 MHz, CDCl3) δ = 176.4, 
164.6, 136.0, 133.6, 130.1, 129.7, 129.4, 128.8, 
128.6, 126.7, 90.4, 77.4, 77.2, 76.9, 39.1, 27.0. I.R 
(thin film) νmax (cm-1): 1732 (C=O). HRMS (ESI): 
m/z calculated for C19H20O4: requires: 335.1254 
for [M+Na]+; found: 335.1270. 
Phenyl(pivaloyloxy)methyl cinnamate 10f 
General procedure D was followed and the crude 
product was purified by column chromatography 
(petroleum ether : ethyl acetate (95:5), Rf = 0.45) 
to give the title compound as a white solid (0.950 
g, 2.81 mmol) in 70% yield. 1H NMR (500 MHz, 
CDCl3) δ = 7.82 (s, 1H, CHPh), 7.77 (d, J = 16.0 
Hz, 1H, CH=CHPh), 7.58 – 7.52 (m, 4H, ArH), 
7.45 – 7.38 (m, 6H, ArH), 6.47 (d, J = 16.0 Hz, 
1H, CH=CHPh), 1.26 (s, 9H, 3xCH3).
 13C NMR 
(125 MHz, CDCl3) δ = 176.4, 164.9, 146.6, 136.1, 
134.3, 130.8, 129.7, 129.1, 128.7, 128.4, 126.7, 
117.2, 90.0, 39.0, 27.1. I.R (thin film) νmax (cm-1): 
1743 (C=O), 1712 (C=O). HRMS (ESI): m/z cal-
culated for C21H22O4: requires: 361.1410 for 
[M+Na]+; found: 361.1436. 
Phenyl(pivaloyloxy)methyl 2-iodobenzoate 10g 
General procedure D was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (95:5)] to give the 
title compound as a colourless oil (1.276 g, 2.91 
mmol) in 73% yield. 1H NMR (500 MHz, CDCl3) 
δ = 8.01 (d, J = 8.0 Hz, 1H, ArH), 7.90 (s, 1H, 
CHPh), 7.82 (d, J = 8.0 Hz, 1H, ArH), 7.62 – 7.60 
(m, 2H, ArH), 7.45 – 7.15 (m, 4H, ArH), 7.16 (t, J 
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= 7.4 Hz, 1H, ArH), 1.27 (s, 9H, 3xCH3).
 13C 
NMR (125 MHz, CDCl3) δ = 176.3, 164.4, 141.7, 
135.6, 134.1, 133.2, 131.5, 129.9, 128.8, 128.1, 
126.9, 94.5, 90.9, 39.1, 27.1. I.R (thin film) νmax 
(cm-1): 1747 (C=O). HRMS (ESI): m/z calculated 
for C19H19O4I: requires: 461.0220 for [M+Na]
+; 
found: 461.0250. 
Phenyl(pivaloyloxy)methyl hexanoate 10h 
General procedure D was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (95:5)] to give the 
title compound as a colourless oil (0.875 g, 2.86 
mmol) in 71% yield. 1H NMR (500 MHz, CDCl3) 
δ = 7.68 (s, 1H, CHPh), 7.51 – 7.39 (m, 5H, ArH), 
2.42 – 2.31 (m, 2H, C(=O)CH2), 1.64 (app quin., 
J = 7.1, 2H, C(=O)CH2CH2), 1.32 – 1.29 (m, 4H, 
C(=O)CH2CH2CH2CH2), 1.23 (s, 9H, 3xCH3), 
0.88 (t, J = 7.0 Hz, 3H, CH3) .
 13C NMR (125 
MHz, CDCl3) δ = 176.4, 171.9, 136.0, 129.7, 
128.7, 126.7, 89.7, 39.0, 34.3, 31.3, 27.0, 24.6, 
22.4, 14.0. I.R (thin film) νmax (cm-1): 1752 (C=O). 
HRMS (ESI): m/z calculated for C18H26O4: re-
quires: 329.1723 for [M+Na]+; found: 329.1746. 
N-Benzyl-2-iodobenzamide 8g43 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (70:30)] to give the 
title compound as a white solid (0.202g, 0.60 
mmol) in 60% yield. 1H NMR (500 MHz, CDCl3) 
δ = 7.85 (d, J = 8.0 Hz, 1H, ArH), 7.41 – 7.30 (m, 
7H, ArH), 7.09 (td, J = 7.5, 1.8 Hz, 1H, ArH), 6.07 
(s, 1H, NH), 4.63 (d, J = 5.8 Hz, 2H, CH2).
 13C 
NMR (125 MHz, CDCl3) δ = 169.3, 142.2, 140.0, 
137.7, 131.3, 128.9, 128.4, 128.3, 127.9, 92.6, 
44.4. 
(S)-N-(1-Phenylethyl)propionamide 8h44 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (60:40)] to give the 
title compound as a white solid (0.128 g, 0.73 
mmol) in 73% yield. [α]D20 = -136 (c 1.0, CHCl3); 
1H NMR (500 MHz, CDCl3) δ = 7.35 – 7.25 (m, 
5H, ArH), 5.65 (s, 1H, NH), 5.16 (app. quin., J = 
7.0 Hz, 1H, CHN), 2.24 – 2.17 (m, 2H, CH2), 1.49 
(d, J = 6.9 Hz, 3H, PhCHCH3), 1.15 (t, J = 7.6 Hz, 
3H, CH2CH3).
 13C NMR (125 MHz, CDCl3) δ = 
172.9, 143.4, 128.8, 127.5, 126.3, 48.7, 30.0, 21.9, 
9.9.  
(S)-N-(1-Phenylethyl)hexanamide 8i 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (60:40)] to give the 
title compound as a pale yellow oil (0.136 g, 0.62 
mmol) in 62% yield. [α]D20 = -61 (c 1.0, EtOH).  
1H NMR (500 MHz, CDCl3) δ = 7.28 – 7.17 (m, 
5H, ArH), 5.63 (s, 1H, NH), 5.07 (app. quin., J = 
7.2 Hz, 1H, CHPh), 2.09 (t, J = 7.4 Hz, 2H, 
C(=O)CH2), 1.56 (app quin., J = 7.4, 2H, 
C(=O)CH2CH2), 1.41 (d, J = 7.0 Hz, 3H, CHCH3), 
1.26 – 1.20 (m, 4H, C(=O)CH2CH2CH2CH2), 0.81 
(t, J = 7.0 Hz, 3H, CH2CH3) .
 13C NMR (125 MHz, 
CDCl3) δ = 172.3, 143.4, 128.8, 127.5, 126.3, 
48.7, 37.0, 31.6, 25.6, 22.5, 21.8, 14.1. I.R (thin 
film) νmax (cm-1): 1634 (C=O amide). HRMS 
(ESI): m/z calculated for C14H21NO: requires: 
242.1515 for [M+Na]+; found: 242.1523 
Methyl cinnamoyl-L-phenylalaninate 8j 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (70:30)] to give the 
title compound as a brown oil (0.194 g, 0.63 
mmol) in 63% yield. [α]D20 = +60 (c 1.0, CHCl3); 
1H NMR (500 MHz, CDCl3) δ = 7.64 (d, J = 15.6 
Hz, 1H, CH=CHPh), 7.51 – 7.49 (m, 2H, ArH), 
7.38 – 7.35 (m, 3H, ArH), 7.31 – 7.25 (m, 3H, 
ArH), 7.13 – 7.11 (m, 2H, ArH), 6.39 (d, J = 15.6 
Hz, 1H, CH=CHPh), 6.07 (d, J = 7.5 Hz, 1H, NH), 
5.04 (m, 1H, CHN), 3.76 (s, 3H, CH3), 3.22 (m, 
2H, CH2Ph).
 13C NMR (125 MHz, CDCl3) δ = 
172.2, 165.4, 142.0, 136.0, 134.8, 130.0, 129.5, 
129.0, 128.8, 128.0, 127.3, 120.1, 53.4, 52.5, 38.1. 
I.R (thin film) νmax (cm-1): 1739 (C=O ester), 1655 
(C=O amide). HRMS (ESI): m/z calculated for 
C19H19NO3: requires: 310.1438 for [M+H]
+; 
found: 310.1437. 
Methyl benzoyl-L-phenylalaninate 8k45 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (70:30)] to give the 
title compound as a yellow oil (0.181 g, 0.64 
mmol) in 64% yield. [α] D20 = +65 (c 1.0, CHCl3); 
1H NMR (500 MHz, CDCl3) δ = 7.74 – 7.71 (m, 
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2H, ArH), 7.51 – 7.41 (m, 3H, ArH), 7.31 – 7.25 
(m, 3H, ArH), 7.15 – 7.12 (m, 2H, ArH), 6.57 (d, 
J = 6.5 Hz, 1H, NH), 5.10 (m, 1H, CHN), 3.77 (s, 
3H, CH3), 3.26 (m, 2H, CH2Ph). 
13C NMR (125 
MHz, CDCl3) δ = 172.2, 167.0, 136.0, 134.0, 
131.9, 129.5, 128.8, 127.3, 127.1, 53.7, 52.6, 38.1.  
(S)-Methyl 2-((((9H-fluoren-9-yl)methoxy)car-
bonyl)amino)-6-(2-phenylacetamido)hexanoate 
8l 
General procedure C was followed to afford a 
crude product that was purified by chromatog-
raphy [Petroleum ether:EtOAc (50:50)]  to give 
the title compound as a white solid in 70% yield 
(0.511 g, 1.02 mmol), m.p. 114-115 °C, [α]D20 = 
+3.50 (c 1.0, CHCl3); 
1H NMR (500 MHz, Chlo-
roform-d) δ 7.83 – 7.71 (m, 2H, ArH), 7.60 (dd, J 
= 7.7, 4.2 Hz, 2H, ArH), 7.40 (tdd, J = 7.5, 2.1, 1.2 
Hz, 2H, ArH), 7.36 – 7.22 (m, 7H, ArH), 5.43 (s, 
1H, NH), 5.37 (d, J = 8.3 Hz, 1H, NH), 4.47 – 4.29 
(m, 3H, CH2CO(O) and CHCO2Me), 4.22 (t, J = 
7.1 Hz, 1H, CHCH2CO(O)), 3.74 (s, 3H, 
CO2CH3), 3.55 (s, 2H, CH2Ph), 3.20 (q, J = 6.7 
Hz, 2H, NCH2CH2CH2CH2CHCO2Me), 1.88 – 
1.76 (m, 1H, NCH2CH2CH2CHaHbCHCO2Me), 
1.72 – 1.60 (m, 1H, 
NCH2CH2CH2CHaHbCHCO2Me), 1.46 (dq, J = 
13.9, 6.7, 6.3 Hz, 2H, 
NCH2CH2CH2CH2CHCO2Me), 1.36 – 1.22 (m, 
2H, NCH2CH2CH2CH2CHCO2Me). 
13C NMR 
(126 MHz, Chloroform-d) δ 173.0, 171.2, 156.1, 
144.0, 143.9, 141.5, 141.5, 135.1, 129.6, 129.2, 
127.9, 127.5, 127.2, 125.22, 125.21, 120.14, 
120.13, 67.2, 53.8, 52.6, 47.3, 44.0, 39.3, 32.2, 
29.1, 22.5. I.R (thin film) νmax (cm-1): 1738, 1690, 
1638 (C=O). HRMS (ESI): m/z calculated for 
C30H32N2O5: requires: 501.2384 for [M+H]
+; 
found: 501.2442. 
 
ASSOCIATED CONTENT  
Complete experimental procedure and relevant 
spectra (13C and 1H NMR spectra) for all com-
pounds.  
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